ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 939

Rab4A Protects from Lupus Nephritis By Limiting Germinal Center Formation and Pro-Inflammatory Expression of GLUT1 and Integrin By Renal Epithelial Cells

Gourav Choudhary1, Nick Huang2, Ryan Kelly3, Thomas Winans4, Manuel Duarte2, Mark Haas5 and Andras Perl2, 1Department of Biochemistry and Mol. Biology, SUNY Upstate Medical University, Syracuse, NY, 2Medicine, SUNY Upstate Medical University, Syracuse, NY, 3SUNY, Syracuse, NY, 4SUNY Upstate Medical University, Syracuse, NY, 5Professor of Pathology, Cedars-Sinai, Los Angeles, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Lupus, SLE and lupus nephritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S109 ACR Abstract: SLE–Animal Models (934–939)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Lupus nephritis is most common cause of mortality and morbidity in systemic lupus erythematosus (SLE) patients and 60% of SLE patients develops lupus nephritis. HRES-1/RAB4 genomic locus has been associated with disease manifestations in SLE patients (Arthritis Rheum. 58:532-520). Inhibition of Rab geranylgeranyl transferase prevented nephritis in lupus-prone mice (Ann. Rheum. Dis. 73:1887-1897). To investigate the role of Rab4A in lupus pathogenesis, we developed a mouse model Rab4A-KOCD4Cre (Rab4AKO; mice lacking expression of Rab4A in T cells relative to C57Bl/6 wild-type (WT) and floxed Rab4AQ72L knock-in (Rab4AQ72L) as a control. Previously we showed that Rab4AQ72L knock-in prevents ANA production, immunoglobulin and C3 depositions in glomeruli and lymphocytic infiltration in kidneys relative to Rab4AKO mice. These preliminary results provided rationale for testing our hypothesis that HRES-1/Rab4 plays a crucial role in SLE, including the pathogenesis of lupus nephritis.

Methods: Age and gender matched WT, Rab4AQ72L and Rab4AKO female mice were injected with 0.5 mL pristane per 20 g of body weight, intraperitoneally. 14 days post pristane injection, kidneys were fixed in formalin for H&E and PAS staining or snap freeze in OCT for confocal microscopy. To assess the podocyte injury, 8 µm frozen kidney sections were analyzed anti-podocin and anti-CD51 (Integrin αV). Frozen kidney sections were further analyzed using anti-CCR6 and anti-IL17. To study the effect of Rab4A on GLUT1 glucose transporter, Kidney sections were stained with anti-GLUT1. Splenic germinal centers were investigated using 6 µm frozen spleen sections stained with anti-B220, anti-F4/80, anti-CD3 and anti-CD138. Kidney histology was blindly evaluated by an expert pathologist.

Results: Kidney histology revealed accelerated glomerulonephritis (GN) (3-fold; p=7.6×10-4), glomerulosclerosis (GS) (8-fold; p=0.0106) in Rab4AKO mice relative to Rab4aQ72L mice. Further, we found 1.7-fold reduction in podocin and 1.9-fold reduction in CD51 expression in kidneys of Rab4AKO relative to WT mice (podocin, p=0.0027; CD51, p= 0.0002) or Rab4aQ72L mice (podocin, p=0.03; CD51, p<0.0001), suggesting podocyte injury in Rab4AKO animals. In addition, CCR6 and IL-17 expression by kidney-infiltrating lymphocytes was significantly higher in Rab4AKO as compared to WT and Rab4aQ72L mice. GLUT1 expression was elevated 4-fold and confined to the kidney medulla of Rab4AKO mice relative to Rab4aQ72L (p=0.004) and WT controls (p= 0.0001). Relative to WT controls, splenic germinal centers exhibited 1.3-fold increased size in Rab4AKO mice (p= 0.0.0452) with 3-fold expansion of T cell zones (p< 0.0001) and 2-fold accumulation of plasma cells (p=0.0197). Interestingly, spleen sections from Rab4aQ72L mice had smaller splenic germinal centers with fewer CD138+ plasma cells in comparison to WT (p=0.0002: p=0.0427) and Rab4AKO mice (p= 0.0083).

Conclusion: The results suggest that Rab4A protects from nephritis in the pristane-induced model of SLE by limiting the germinal center formation and pro-inflammatory expression of GLUT1 and Integrin αV by renal epithelial cells.


Disclosure: G. Choudhary, None; N. Huang, None; R. Kelly, None; T. Winans, None; M. Duarte, None; M. Haas, None; A. Perl, None.

To cite this abstract in AMA style:

Choudhary G, Huang N, Kelly R, Winans T, Duarte M, Haas M, Perl A. Rab4A Protects from Lupus Nephritis By Limiting Germinal Center Formation and Pro-Inflammatory Expression of GLUT1 and Integrin By Renal Epithelial Cells [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/rab4a-protects-from-lupus-nephritis-by-limiting-germinal-center-formation-and-pro-inflammatory-expression-of-glut1-and-integrin-by-renal-epithelial-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rab4a-protects-from-lupus-nephritis-by-limiting-germinal-center-formation-and-pro-inflammatory-expression-of-glut1-and-integrin-by-renal-epithelial-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology